Ernexa Therapeutics Inc. (ERNA) Gross margin 2024–2025
Ernexa Therapeutics Inc. (ERNA) gross margin by fiscal year — reported gross profit divided by reported revenue.
83.5%FY2025 · since FY2024: -247.1% → 83.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 83.5% | +330.6 pp |
| FY2024 | -247.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice